Skip to main content
Year archive

AVACTA GROUP PLC — 2025 filings

All 47 regulatory filings released by AVACTA GROUP PLC (AVCT) in 2025, sourced directly from the official regulator.

47 Filings
2025 Period
2025 filings (47)
Filing Released Lang
Avacta reports new AVA6103 pharmacology data
Regulatory Filings
2025-12-18 English
Faridoxorubicin Phase 1b SGC data
Regulatory Filings
2025-12-17 English
Preliminary Data in Faridoxorubicin Phase 1b Trial
Regulatory Filings
2025-12-08 English
Completion of Placing and TVR
Share Issue/Capital Change
2025-11-03 English
Block Listing Six Monthly Return
Share Issue/Capital Change
2025-10-27 English
Avacta presents preclinical data at AACR-NCI-EORTC
Regulatory Filings
2025-10-27 English
Notice of Investor Presentation
Investor Presentation
2025-10-23 English
Equity fundraise of £16 million
Capital/Financing Update
2025-10-20 English
Avacta Presents Phase 1a Data for Faridoxorubicin
Regulatory Filings
2025-10-20 English
Avacta to present data at EORTC-NCI-AACR
Regulatory Filings
2025-10-13 English
Interim Half Year Results 2025
Interim / Quarterly Report H1 2025
2025-09-30 English
Notice of Interim Results
Report Publication Announcement
2025-09-15 English
Shortlisted for AIM Awards Technology of the Year
Regulatory Filings
2025-09-09 English
Avacta completes sale of Coris Bioconcept
Regulatory Filings
2025-09-01 English
Amendments to Convertible Bond + equity fundraise
Regulatory Filings
2025-08-29 English
Avacta to Present at ESMO Congress
Earnings Release FY 2025
2025-07-30 English
Agreement to Sell Coris Bioconcept SRL
M&A Activity
2025-07-28 English
Payment of Convertible Bond Installment
Regulatory Filings
2025-07-21 English
Equity fundraise of £3.25 million
Capital/Financing Update
2025-07-17 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements
2025-07-02 English
Q2 2025 Business Update
Regulatory Filings
2025-07-02 English
Management Team Appointments
Board/Management Information
2025-07-01 English
Appointment of Zeus Capital as Joint Broker
Regulatory Filings
2025-06-30 English
New Response in Phase 1b Trial
Regulatory Filings
2025-06-19 English
Posting of Annual Report and Revised Notice of AGM
Report Publication Announcement
2025-06-09 English
Preliminary Full Year 2024 Results
Earnings Release FY 2024
2025-06-06 English
Avacta Change in Prelim Date Part 2
Report Publication Announcement
2025-06-04 English
Board appointments
Board/Management Information
2025-05-28 English
Update on timing of preliminary results
Report Publication Announcement
2025-05-27 English
Notice of Results
Report Publication Announcement
2025-05-15 English
Investor Webinar
Regulatory Filings
2025-05-12 English
Block Listing Application to AIM
Share Issue/Capital Change
2025-05-08 English
Board change
Board/Management Information
2025-04-29 English
Block Listing Six Monthly Return
Share Issue/Capital Change
2025-04-28 English
Avacta presents preclinical data at AACR
Regulatory Filings
2025-04-28 English
Avacta presents data from lead candidate at AACR
Regulatory Filings
2025-04-28 English
Issue of Equity and Total Voting Rights
Share Issue/Capital Change
2025-04-23 English
Avacta Quarterly Update
Regulatory Filings
2025-03-31 English
Avacta Announces Presentations at AACR
Regulatory Filings
2025-03-26 English
Avacta Completes Launch Diagnostics Sale
M&A Activity
2025-03-25 English
Avacta to Present at Leerink Healthcare Conference
Report Publication Announcement
2025-03-10 English
Avacta announces data update for AVA6000
Earnings Release Q1 2025
2025-03-07 English
Avacta to sell Launch Diagnostics
Regulatory Filings
2025-03-07 English
Appointment of Joint Broker
Board/Management Information
2025-02-04 English
Issue of Equity and Total Voting Rights
Share Issue/Capital Change
2025-01-21 English
Avacta Announces Data from AVA6000 Phase 1 trial
Earnings Release Q1 2025
2025-01-16 English
Avacta Appoints Chief Financial Officer
Board/Management Information
2025-01-13 English